medline.ch Dermatologie Tumoren Melanom

	Exosomes as key mediators in immune and cancer cell interactions: insights in melanoma progression and therapy. Arch Dermatol Res Hsu CY, Chandramoorthy HC, Mohammed JS, Al-Hasnaawei S, Yaqob M, Kundlas M, Samikan K, Sahoo S, Sunori SK, Abbas ZA. PMID: 40252131 [PubMed - indexed for MEDLINE]
	New Dermoscopy Pattern in Nevus-Associated Melanomas. Pigment Cell Melanoma Res Lobos-Guede N, Hartmann D, Darlic V, Carrera C, Alos L, Puig S. PMID: 40252012 [PubMed - indexed for MEDLINE]
	Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial. J Transl Med Bulgarelli J, Piccinini C, Scarpi E, Gentili G, Renzi L, Carloni S, Limarzi F, Pancisi E, Granato AM, Petrini M, De Rosa F, Guidoboni M, Fanelli D, Tumedei MM, Tazzari M, Baravelli S, Bronico I, Cortesi P, Pignatta S, Capelli L, Ancarani V, Foschi G, Turci L, Tauceri F, Framarini M, Ridolfi L. PMID: 40251644 [PubMed - indexed for MEDLINE]
	Clinical validation of droplet digital PCR assays in detecting BRAF(V600)-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial. Lancet Oncol Syeda MM, Long GV, Garrett J, Atkinson V, Santinami M, Schadendorf D, Hauschild A, Millward M, Mandala M, Chiarion-Sileni V, Smylie M, Manikhas GM, Dummer R, Wiggins JM, Ali S, Adnaik SB, Tan M, Dajee M, Polsky D. PMID: 40250457 [PubMed - as supplied by publisher]
	Unexpected Diagnosis of Malignant Melanoma: Clinical Presentation and Pathologic Findings. Dermatol Surg Olshinka A, Litwin A, Didkovski E, Levi A, Noyman Y, Feinmesser M. PMID: 40249075 [PubMed - as supplied by publisher]
	Impact of steroid dose and timing on efficacy of combination PD-1/CTLA-4 blockade. Oncoimmunology Curkovic NB, Irlmeier R, Bai X, Cui C, Ye F, Burnette HR, Lawless AR, Czapla JA, Sullivan R, Johnson DB. PMID: 40248956 [PubMed - indexed for MEDLINE]
	Exhaled breath analysis with the use of an electronic nose to predict response to immune checkpoint inhibitors in patients with metastatic melanoma: melaNose trial. Front Immunol van Dijk B, Schoenaker IJH, van der Veldt AAM, de Groot JWB. PMID: 40248699 [PubMed - indexed for MEDLINE]
	Pulmonary Metastasectomy for Melanoma. Thorac Surg Clin Moonsamy P, Hompe E, Boland GM. PMID: 40246412 [PubMed - indexed for MEDLINE]
	Genetic landscape of uveal melanoma in Southeast Asia: high 1q gains and unique patterns of metastasis risk. Eye Vis (Lond) Chen C, Wang MM, Lim AST, Heng EYH, Tien SL, Shen SY, Tan GSW, Chan JY, Chan ASY. PMID: 40241171 [PubMed]
	Digital PCR-based genetic profiling from vitreous fluid as liquid biopsy for primary uveal melanoma: a proof-of-concept study. J Exp Clin Cancer Res Nell RJ, Versluis M, Menger NV, Gelmi MC, Vu THK, Verdijk RM, Luyten GPM, Jager MJ, van der Velden PA. PMID: 40240901 [PubMed - indexed for MEDLINE]
	Risk of Nonmelanoma Skin Cancers and Cutaneous Melanoma after Psoralen and Ultraviolet A Therapy in Psoriasis Patients: A Nationwide Taiwanese Cohort Study. Clin Exp Dermatol Ko MJ, Tsai WC, Tsai PH, Hsu LY, Chien KL, Wu HY. PMID: 40239024 [PubMed - as supplied by publisher]
	Correction: Economic Evaluation of Inguinal Versus Ilio-inguinal Lymphadenectomy for Patients with Stage III Metastatic Melanoma to Groin Lymph Nodes: Evidence from the EAGLE FM Randomized Trial. Ann Surg Oncol Mahumud RA, Law CK, Ospino DA, de Wilt JHW, van Leeuwen BL, Allan C, de Lima Vazquez V, Jones RP, Howle J, Peric B, Spillane AJ, Morton RL. PMID: 40238066 [PubMed - as supplied by publisher]
	Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols. Dermatol Reports Pélouard F, Chedru-Legros V, Nganoa C, Dompmartin A, L'Orphelin JM. PMID: 40237146 [PubMed - as supplied by publisher]
	Radiotherapy has a survival advantage over surgery in patients with choroidal melanoma: a retrospective cohort study of 6,871 patients. Front Surg Wu Y, Shi L, Ye Z, Zhou Y, Wang F, Zhang Y. PMID: 40236990 [PubMed]
	A new era in melanoma immunotherapy: focus on DCs metabolic reprogramming. Cancer Cell Int Nour MA, Rajabivahid M, Mehdi MSS, Tahmasebi S, Dashtgol SN, Dehghani-Ghorbi M, Vanan AG, Ghorbaninezhad F. PMID: 40234886 [PubMed]
	Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial. J Immunother Cancer Block MS, Nelson GD, Chen J, Johnson S, Yang L, Flotte TJ, Grewal EP, McWilliams RR, Kottschade LA, Domingo-Musibay E, Markovic SN, Dimou A, Montane HN, Piltin MA, Price DL, Khariwala SS, Hui JYC, Erskine CL, Strand CA, Zahrieh D, Dong H, Hieken TJ. PMID: 40234093 [PubMed - indexed for MEDLINE]
	Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open. Am Soc Clin Oncol Educ Book Joshi UM, Hundal J, Mata JR, Schollenberger MD, Warrier G, Luke JJ, Lipson EJ, Funchain P. PMID: 40233298 [PubMed - indexed for MEDLINE]
	A 39-Year Nationwide Study of Uveal Melanoma in Taiwan. Cancer Med Chao AN, Chao A, Chang WY, Wang CC, Tsai YJ, Chen KJ, Hwang YS, Yang LY. PMID: 40231836 [PubMed - indexed for MEDLINE]
	Local recurrence of non-lentigo maligna melanoma in situ and safety excision margins: A systematic review. J Dtsch Dermatol Ges Dessinioti C, Befon A, Stratigos AJ. PMID: 40231559 [PubMed - as supplied by publisher]
	Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies. Pigment Cell Melanoma Res de Arruda JAA, Drumond VZ, Tenório JR, Abreu LG, Silva TA, Mesquita RA, de Andrade BAB. PMID: 40229937 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 42598

Seite 1 von 2130

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung